This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase II, open-label, multicenter, randomized st...
Clinical trial

A phase II, open-label, multicenter, randomized study to investigate the efficacy and safety of MPDL3280a (Anti-PD-L1 Antibody) compared with docetaxel in patients with Non-Small Cell Lung Cancer after platinum failure

Read time: 1 mins
Last updated:8th Aug 2013
To estimate the efficacy of MPDL3280A compared with docetaxel as measured by OS To evaluate the safety and tolerability of MPDL3280A compared with docetaxel
Category Value
Study start date 2013-08-08

View full details